Letters to the Editor: It's always been an uphill battle to secure disability rights. Under Trump, it's ‘scary'
In 1973, the Rehabilitation Act added several sections that advocated for the disabled, and in 1975, the Education for All Handicapped Children Act was implemented. These were important moves that supported the disability rights movement.
In my 43 years in disability education, I have witnessed and celebrated disabled individuals flourishing because of the reasonable accommodations and equal access that the ADA and its precursors mandated. With education and Medicare funding on the chopping block, and our current president openly mocking the disabled, it's become scary. The fight continues.
Judy Marks, Los Angeles
..
To the editor: My life and the lives of thousands of other disabled people have been positively affected by all the inalienable rights written in the ADA.
The bill allowed our community to thrive in schools with individualized education programs and student inclusion. We were given equal opportunities in the workplace with accessible modifications. We had greater freedom with more outdoor access thanks to added curb cuts and building entrances and exits that accommodate the disabled.
I live in an apartment building for independent-living residents. Many depend on in-home supportive services for their independence. What will become of these services under this administration?
Weakening the ADA would be a backward step. Why would the most powerful country in the world choose to go backward?
Julie Inman, Irvine
..
To the editor: My heart goes out to those who truly need the assistance that has been afforded by the ADA. However, too many small businesses have been the targets of 'gotcha' lawsuits stemming from abuse of this law. Many of those filing these 'gotcha' suits have only one goal in mind: enriching themselves. Loopholes in the ADA must be fixed, or these frivolous and expensive lawsuits will continue to harm California and its small businesses.
Senate Bill 84 aims to address these abuses. It is essential that the reform legislation receives a fair hearing, answering the pleas of many small-business owners across the state.
Barry E. Zanck, Newport Beach
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
12 hours ago
- Forbes
Congress May Finally Be Addressing The Nation's Doctor Shortage
There may finally be bipartisan momentum to lifting a cap that Congress put on Medicare-funded residency slots nearly three decades ago. The Association of American Medical Colleges for years has been working with members of Congress to find ways to increase federal support for medical education and residency slots, in particular. Medicare health insurance for the elderly is the primary source for graduate medical education (GME) in the U.S., but the Balanced Budget Act of 1997 capped the number of residents and fellows in an effort to reign in federal spending. But legislation signed into law by Republican President Donald Trump in his first term and a second phase under Democratic President Joe Biden added some new slots such as when new teaching hospitals open or rural hospitals add new programs. But the 1,200 or so residency slots funded under those respective year-end spending packages signed under those administrations won't put a dent in a physician shortage projected at up to 86,000 physicians by 2036, the AAMC says. Lately, members of Congress are feeling the heat from their constituents, particularly in rural areas about the shortage of physicians. That shortage could also worsen following the passage of Trump's One Big Beautiful Bill Act, which cuts $1 trillion from Medicaid and health plans under the Affordable Care Act and is expected to eliminate health insurance coverage for nearly 12 million Americans over the next decade, data from the Congressional Budget Office shows. 'What we are trying to do is increase the cap . . . so we can have more residency programs so we can start to stem the shortfall (of physicians),' U.S. Sen. John Boozman, an Arkansas Republican, said earlier this week during an interview on 'The Julie Mason Show' on SiriusXM's POTUS Politics channel discussing ways to ensure quality healthcare in rural America. Boozman and fellow Senators Raphael Warnock, a Georgia Democrat, Republican Susan Collins of Maine and Democrat Chuck Schumer of New York this summer introduced the Resident Physician Shortage Reduction Act of 2025. This bipartisan legislation would help grow the physician workforce and improve access to care for patients nationwide, the AAMC says. The legislation would gradually increase the number of Medicare-funded residency positions by 14,000 over seven years, 'making key investments in physician training in rural and urban communities across the country,' the AAMC says. 'Patients across the country are already feeling the effects of a strained physician workforce,' said Dr. David J. Skorton, president and chief executive officer of the AAMC, which includes 160 U.S. medical schools and nearly 500 academic health systems and teaching hospitals as its members. 'This crucial bill, along with its House companion, would build upon recent bipartisan success to expand federal support for residency training and improve access to care for patients everywhere," Skorton added. "This legislation represents a strong, bipartisan commitment to expanding the physician workforce and improving health care outcomes.'
New York Post
12 hours ago
- New York Post
House GOP broadens Medicare fraud probe at Florida organ transplant center
WASHINGTON — House Republicans are demanding records from a Florida-based organ procurement center after a whistleblower alleged a possible Medicare fraud scheme involving staff members overbilling for work hours and improperly reimbursing for personal costs or other expenses. The House Ways and Means Committee fired off a letter Thursday to the Life Alliance Organ Recovery about the purported scheme, also citing a troubling report involving a patient who had also been kicked off life support but was still 'crying and biting on his breathing tube' as clinicians 'waited for death.' 'One Life Alliance employee interpreted' the response 'as the patient not wanting to die,' stated the letter sent by Ways and Means Chairman Jason Smith (R-Mo.) and Subcommittee on Oversight Chairman David Schweikert (R-Ariz.) to Life Alliance Organ Recovery Center executive director Clifton McClenney. 4 House Ways and Means Committee Chairman Jason Smith (R-Mo.) is demanding records from a Florida-based organ procurement center after a whistleblower alleged a possible Medicare fraud scheme. Getty Images Smith called the 'potential Medicare reimbursement fraud' — which may have included abuse of the organization's tax-exempt status 'to enrich board members or senior leadership' — as well as current reports on the quality of donor care at the center 'deeply, deeply disturbing.' 'Among the most concerning statements are those regarding the misuse of taxpayer dollars, including that Life Alliance staff members were encouraged to increase their hours and bill Medicare for hours not worked; Life Alliance received reimbursement from Medicare for costs associated with the personal use of a company vehicle; and Life Alliance double dipped on its Medicare Cost Report ('MCR') for certain expenses,' Smith said in the missive. 'The Committee on Ways and Means,' he added, 'is concerned that if these allegations were verified, they would constitute a violation of the False Claims Act.' 4 The committee cited a troubling report involving a patient who had also been kicked off life support but was still 'crying and biting on his breathing tube' as clinicians 'waited for death.' The records request comes after a 2021 resolution of three lawsuits against the University of Miami, of which the center's surgery department is a division, alleging False Claims Act violations. Those had accused the center of 'ordering medically unnecessary laboratory tests and submitting false claims for pre-transplant lab testing,' noted Smith's letter, which was also addressed to University of Miami President Joseph Echevarria. In 2015, Life Alliance had also been found to be a member not in good standing due to other concerns about the level of care and patient safety. 4 In 2015, Life Alliance had also been found to be a member not in good standing due to other concerns about the level of care and patient safety. 'Tax-exempt organ procurement organizations save the lives of countless Americans each year, but the success of our nation's organ transplant network depends on these organizations maintaining the public's trust and operating within their stated tax-exempt purpose,' the chairman said in a statement. 'The Ways and Means Committee will not rest until these organizations are held accountable and public trust is restored.' The Republican-led panel's inquiry follows similar investigations into organ transplant nonprofits in Indiana, Oklahoma and New Jersey, according to a report in the Free Press, which also cited possible overbilling for Medicare costs — including for the potential use of a private jet for personal trips. 4 Life Alliance Organ Recovery Center executive director Clifton McClenney was hit with the records request Thursday. That came on the heels of investigations by the Department of Health and Human Services' Office of Inspector General finding instances of improper Medicare reimbursements. Smith has asked Life Alliance to hand over by Aug. 14 its accounting records on Medicare costs, service contracts, financial interests, business relationships and all documents on its policies, conduct, practices and procedures that may touch on potential federal violations. McClenney, Life Alliance and Echevarria did not immediately respond to requests for comment.
NBC News
a day ago
- NBC News
Trump gives drugmakers 60 days to slash prescription drug prices
President Donald Trump sent letters to more than a dozen major drugmakers Thursday demanding that they lower the cost of prescription drugs in the U.S. within 60 days. In the letters — which Trump published on his social media platform Truth Social — the drugmakers were told to offer the 'full portfolio' of their existing medications to Medicaid patients at the same prices paid abroad, also known as the 'most favored nation' rule. He also told drugmakers to 'guarantee' that patients on Medicare, Medicaid and private insurance get the same lower prices that are paid abroad for all newly approved drugs 'both upon launch and moving forward.' He also demanded that drugmakers return any additional revenues earned abroad to U.S. taxpayers, and create a 'direct to consumer' option for certain medications that would also be offered at lower prices. 'Make no mistake: a collaborative effort towards achieving global pricing parity would be the most effective path for companies, the government, and American patients,' Trump wrote in the letters. 'But if you refuse to step up, we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices.' It's unclear, experts say, whether Trump has the authority to force drugmakers to lower the cost of their prescription drugs without the help of Congress. What's more, any attempt to do so is likely to be met with fierce pushback from the drug industry. 'It may take more than a tough letter from the President to motivate the pharmaceutical industry to drop their prices,' said Tricia Neuman, executive director of the program on Medicare policy at KFF, a nonpartisan health policy research group. 'The voluntary approach hasn't worked so far to drive down drug prices,' she added. 'Drug prices tend to go down when compelled by law or in response to competition.' Trump has repeatedly complained — during both terms — that people in the U.S. pay far more for prescription drugs than people in other countries. Indeed, prescription drug prices in the United States are notoriously high — up to 10 times more than in other nations of similar size and wealth, according to the Rand Corp., a public policy think tank. More than 3 in 4 adults in the U.S. say the cost of medications is unaffordable, according to a poll from KFF. In May, Trump signed an executive order instructing federal health officials to renew an effort to implement the 'most favored nation' rule — a strategy he pursued unsuccessfully during his first term. The 17 letters were sent Thursday to major drugmakers such as Eli Lilly, GSK, Pfizer, Merck, Johnson & Johnson, Amgen, Novo Nordisk and Novartis. NBC News has reached out to all 17 companies for comment. A spokesperson for Novo Nordisk said the company 'remains focused on improving patient access and affordability, and we will continue to work to find solutions that help people access the medication they need.' A spokesperson for Johnson & Johnson said the company was still reviewing the letter, and referred NBC News to the pharmaceutical industry's top lobbying group, PhRMA, for comment. PhRMA did not immediately respond to a request for comment. The Trump administration does have another tool at its disposal to lower the cost of prescription drugs: Medicare drug pricing negotiations. Signed into law by President Joe Biden through the Inflation Reduction Act, the provision allows Medicare to negotiate prices on the costliest medications. The first round of negotiations is estimated to save Medicare $6 billion in 2026, when the prices are expected to go into effect.
